Milward Francis | Head Of Global Assay, Services Vaccine R&D
Boehringer Ingelheim

Milward Francis, Head Of Global Assay, Services Vaccine R&D, Boehringer Ingelheim

Michel is a business development and licensing professional with experience in all steps of business transaction processes within the global pharmaceutical, biotechnology and diagnostics industries. He joined the Global Business Development & Licensing group of MSD a bit more than 3 years ago. The goal is to augment the pipeline for MSD and he is responsible for search and evaluation of opportunities in Europe and the Middle East in the therapeutic areas of Infectious Diseases & Vaccines, Immunological, Cardiometabolic & Respiratory diseases.

Appearances:



Day 2, April 8 @ 09:10

Panel: The Future of the Animal Health Business

  • Discussing the emerging trends in animal health & biologics (companion and production animals)
  • The emergence of human health technologies in the animal health space; Are these technologies too expensive to implement in animal health?
  • The importance of establishing strong collaboration/partnerships for advancing animal health innovation
  • What about emerging markets? - Finding success in Latin America, China & India etc.
Mahesh Kumar, Senior Vice President, Global Biologics Research, Zoetis
Milward Francis, Head Of Global Assay, Services Vaccine R&D, Boehringer Ingelheim
Stephen Wu, Research Fellow, Global Product Development, China R&D, Elanco
last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates